Phosphorylation of protein phosphatase type-1 inhibitory proteins by integrin-linked kinase and cyclic nucleotide-dependent protein kinases

被引:34
|
作者
Erdödi, F
Kiss, E
Walsh, MP
Stefansson, B
Deng, JT
Eto, M
Brautigan, DL
Hartshorne, DJ
机构
[1] Univ Debrecen, Med & Hlth Sci Ctr, Dept Med Chem, H-4012 Debrecen, Hungary
[2] Univ Calgary, Smooth Muscle Res Grp, Calgary, AB T2N 4N1, Canada
[3] Univ Calgary, Canadian Inst Hlth Res Grp Regulat Vasc Contracti, Fac Med, Calgary, AB T2N 4N1, Canada
[4] Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA
[5] Univ Arizona, Muscle Biol Lab, Tucson, AZ 85721 USA
关键词
C-kinase-enhanced (potentiated) phosphatase inhibitors (CPI-17 and KEPI); myosin phosphatase; protein kinase A; protein kinase G;
D O I
10.1016/S0006-291X(03)00976-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein phosphatases play key roles in cellular regulation and are subjected to control by protein inhibitors whose activity is in turn regulated by phosphorylation. Here we investigated the possible regulation of phosphorylation-dependent type-1 protein phosphatase (PP1) inhibitors, CPI-17, PHI-1, and KEPI, by various kinases. Protein kinases A (PKA) and G (PKG) phosphorylated CPI-17 at the inhibitory site (T38), but not PHI-1 (T57). Phosphorylated CPI-17 inhibited the activity of both the PP1 catalytic subunit (PP1c) and the myosin phosphatase holoenzyme (MPH) with IC50 values of 1-8 nM. PKA predominantly phosphorylated a site distinct from the inhibitory T73 in KEPI, whereas PKG was ineffective. Integrin-linked kinase phosphorylated KEPI (T73) and this dramatically increased inhibition of PP1c (IC50 = 0.1 nM) and MPH (IC50 = 8 nM). These results suggest that the regulatory phosphorylation of CPI-17 and KEPI may involve distinct kinases and signaling pathways. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:382 / 387
页数:6
相关论文
共 50 条
  • [1] CYCLIC NUCLEOTIDE-DEPENDENT PROTEIN-KINASES AND PROTEIN-PHOSPHORYLATION
    GILL, GN
    FEDERATION PROCEEDINGS, 1978, 37 (06) : 1302 - 1302
  • [2] CYCLIC NUCLEOTIDE-DEPENDENT PROTEIN-KINASES
    CORBIN, J
    WOODFORD, T
    MCKNIGHT, S
    WOLFE, L
    FASEB JOURNAL, 1988, 2 (05): : A1330 - A1330
  • [3] CYCLIC NUCLEOTIDE-DEPENDENT PROTEIN-KINASES
    SCOTT, JD
    PHARMACOLOGY & THERAPEUTICS, 1991, 50 (01) : 123 - 145
  • [4] PROTEIN MODULATION OF CYCLIC NUCLEOTIDE-DEPENDENT PROTEIN-KINASES
    WALTON, GM
    GILL, GN
    METHODS IN ENZYMOLOGY, 1983, 99 : 206 - 212
  • [5] PHOSPHORYLATION OF TYROSINE AMINOTRANSFERASE INVITRO BY CYCLIC NUCLEOTIDE-DEPENDENT PROTEIN-KINASES
    STELLWAGEN, RH
    KOHLI, KK
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1981, 102 (04) : 1209 - 1215
  • [6] PHOSPHORYLATION OF HIGH MOBILITY GROUP 14 PROTEIN BY CYCLIC NUCLEOTIDE-DEPENDENT PROTEIN-KINASES
    WALTON, GM
    SPIESS, J
    GILL, GN
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1982, 257 (08) : 4661 - 4668
  • [7] INHIBITORY EFFECTS OF CORDYCEPIN ON CYCLIC NUCLEOTIDE-DEPENDENT AND CYCLIC NUCLEOTIDE-INDEPENDENT PROTEIN-KINASES
    GLAZER, RI
    KUO, JF
    BIOCHEMICAL PHARMACOLOGY, 1977, 26 (14) : 1287 - 1290
  • [8] Mechanisms of autoinhibition in cyclic nucleotide-dependent protein kinases
    Francis, SH
    Poteet-Smith, C
    Busch, JL
    Richie-Jannetta, R
    Corbin, JD
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2002, 7 : D580 - D592
  • [9] CYCLIC NUCLEOTIDE-DEPENDENT PROTEIN KINASES OF RAT PANCREAS
    VANLEEMP.M
    CAMUS, J
    CHRISTOPHE, J
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1973, 54 (01) : 182 - 190
  • [10] Allosteric regulation of cyclic nucleotide-dependent protein kinases
    Pomier, Karla Martinez
    Akimoto, Madoka
    Byun, Jung Ah
    Khamina, Mariia
    Melacini, Giuseppe
    CANADIAN JOURNAL OF CHEMISTRY, 2022, 100 (09) : 649 - 659